FA-O'DIDE: Feasibility and Acceptability Study of the "O'Dide" Application in People Suffering From an Addiction

Sponsor
University Hospital, Toulouse (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04659954
Collaborator
Institut de Recherche en Santé Publique, France (Other)
30
1
1
12
2.5

Study Details

Study Description

Brief Summary

Substance Use Disorders (SUD) are associated with cognitive schemas that lead to care attrition and mistrust towards care. Considering this within SUD management, it is important to establish a confident relation between the patient and the care team to favorize acre observance. However, it demands an important availability of the healthcare team, allowing for frequent interactions at all times, including at night and during days off. We postulated that an application called Ô DIDE for Digital Interaction for Detoxification Engagement, that aims to help the caregivers maintaining a link with the patient in order to facilitate confidence in the relationship, could favorize care observance especially consumption report.

Condition or Disease Intervention/Treatment Phase
  • Other: Application O'DIDE
N/A

Detailed Description

The present research aims to assess the feasibility of the "Ô DIDE" application after 8 weeks of use by patients treated for a disorder related to substance use at the Toulouse University Hospital.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Feasibility and Acceptability Study of the "O'Dide" Application in People Suffering From an Addiction
Anticipated Study Start Date :
Apr 1, 2021
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Apr 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Application O'DIDE

The subjects will use the application O'DIDE during 8 weeks

Other: Application O'DIDE
The intervention is the use of an application that aimed to favorize contact between the patient and the care team between the consultations.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of the application O'DIDE [8 weeks]

    Percentage of patients who logged on at least once a week to the application during the 8 weeks of availability of the O'DIDE application

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Suffering from any type of addiction, with an active addiction requiring weekly monitoring of consumption

  • Possessing an Android smartphone or having access to an Android smartphone and having access to an internet connection

  • Able to read and understand French

  • Affiliated or beneficiary of a social security scheme.

  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research).

Exclusion Criteria:
  • Patient with cognitive or psychiatric disorders that may affect their ability to consent

  • Participation in another protocol involving a modification of the treatment for addiction

  • Person under legal protection, guardianship or curatorship

  • Known or suspected pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 University hospital of Toulouse Toulouse France 31059

Sponsors and Collaborators

  • University Hospital, Toulouse
  • Institut de Recherche en Santé Publique, France

Investigators

  • Principal Investigator: Juliette Salles, MD, University Hospital, Toulouse

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Toulouse
ClinicalTrials.gov Identifier:
NCT04659954
Other Study ID Numbers:
  • RC31/20/0367
First Posted:
Dec 9, 2020
Last Update Posted:
Dec 9, 2020
Last Verified:
Dec 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Toulouse
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 9, 2020